BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21566551)

  • 1. New and innovative interventions in the management of pemphigus.
    Frydman AS; Fairley JA
    G Ital Dermatol Venereol; 2011 Jun; 146(3):211-24. PubMed ID: 21566551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in pemphigus therapy.
    Prajapati V; Mydlarski PR
    Skin Therapy Lett; 2008 Apr; 13(3):4-7. PubMed ID: 18506357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current therapy of the pemphigus group.
    Kasperkiewicz M; Schmidt E; Zillikens D
    Clin Dermatol; 2012; 30(1):84-94. PubMed ID: 22137231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adjuvant therapy of pemphigus. An update.
    Bystryn JC; Steinman NM
    Arch Dermatol; 1996 Feb; 132(2):203-12. PubMed ID: 8629830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for the management of pemphigus vulgaris.
    Harman KE; Albert S; Black MM;
    Br J Dermatol; 2003 Nov; 149(5):926-37. PubMed ID: 14632796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus.
    Frew JW; Martin LK; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):599-606. PubMed ID: 21925004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of mucous membrane pemphigoid and pemphigus.
    Knudson RM; Kalaaji AN; Bruce AJ
    Dermatol Ther; 2010; 23(3):268-80. PubMed ID: 20597945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017.
    Harman KE; Brown D; Exton LS; Groves RW; Hampton PJ; Mohd Mustapa MF; Setterfield JF; Yesudian PD
    Br J Dermatol; 2017 Nov; 177(5):1170-1201. PubMed ID: 29192996
    [No Abstract]   [Full Text] [Related]  

  • 9. Current therapy of pemphigus vulgaris.
    Fellner MJ; Sapadin AN
    Mt Sinai J Med; 2001; 68(4-5):268-78. PubMed ID: 11514914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The actual management of pemphigus.
    Daniel BS; Murrell DF
    G Ital Dermatol Venereol; 2010 Oct; 145(5):689-702. PubMed ID: 20930702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris.
    Turner MS; Sutton D; Sauder DN
    J Am Acad Dermatol; 2000 Dec; 43(6):1058-64. PubMed ID: 11100023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pemphigus vulgaris: a therapeutic option for disease control.
    da Silva AV; Valones MA; Guimaraes RP; de Castro JF; Carvalho Ade A
    Gen Dent; 2008; 56(7):700-3. PubMed ID: 19014030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete remission of drug-resistant Pemphigus vegetans treated by extracorporeal photopheresis.
    Kaiser J; Kaatz M; Elsner P; Ziemer M
    J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):843-4. PubMed ID: 17567330
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment failure with rituximab in a patient with pemphigus vulgaris.
    Weger W; Aberer E
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):387-9. PubMed ID: 18269618
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic plasma exchange as a crisis option in severe pemphigus vulgaris.
    Ranugha PS; Kumari R; Kartha LB; Parameswaran S; Thappa DM
    Indian J Dermatol Venereol Leprol; 2012; 78(4):508-10. PubMed ID: 22772632
    [No Abstract]   [Full Text] [Related]  

  • 16. Pemphigus treatment in Japan.
    Tanikawa A; Amagai M
    Dermatol Clin; 2011 Oct; 29(4):685-6. PubMed ID: 21925019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid.
    Mazzi G; Raineri A; Zanolli FA; Da Ponte C; De Roia D; Santarossa L; Guerra R; Orazi BM
    Transfus Apher Sci; 2003 Feb; 28(1):13-8. PubMed ID: 12620264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins.
    Shimanovich I; Nitschke M; Rose C; Grabbe J; Zillikens D
    Br J Dermatol; 2008 Feb; 158(2):382-8. PubMed ID: 18070210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab).
    Morrison LH
    J Am Acad Dermatol; 2004 Nov; 51(5):817-9. PubMed ID: 15523367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe pemphigus vulgaris of the scalp with adjuvant rituximab and immunoadsorption.
    Kamphausen I; Schulze F; Schmidt E; Zillikens D; Kunz M
    Eur J Dermatol; 2012; 22(6):786-7. PubMed ID: 23114083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.